Disposable Plastic Blood Bag Market Report

The global disposable plastic blood bag market is expected to expand as it rides on increasing awareness about blood donation. High adoption of disposable blood bag because of its advantageous features and low risk of infection associated with its use could add to the growth of the global disposable plastic blood bag market. Increased incidence of accidental or traumatic injuries is anticipated to augment the demand for disposable plastic blood bag. In May 2019, Fresenius Kabi, a German healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition, conducted the seventh Fresenius Kabi China Blood Donation Activity.

Important Points to Remember

●  High prevalence of blood disorders to create strong demand for disposable plastic blood bag

●  Players to open new facilities to increase their presence in the global disposable plastic blood bag market

●  Adoption of single blood bags to grow in the near future

●  Blood banks to significantly increase the demand for disposable plastic blood bag

●  Europe to collect a robust share of the global disposable plastic blood bag market

Government Initiatives and Incentives Promoting Blood Donation to Increase Demand

Government programs including blood donor incentives that encourage people to donate blood are expected to create market growth opportunities for disposable plastic blood bag manufacturers. Secondary factors such as rise in the incidence of blood disorders and lifestyle-related and chronic diseases and increasing geriatric population could push forward the demand for disposable plastic blood bag. Certain advantages over glass blood bottles such as low risk of breakage when collecting and transporting blood are anticipated to promote the adoption of disposable plastic blood bag. Glass blood bottles require excessive cleaning and autoclaving.

Manufacturers to Launch More Facilities to Expand Market Presence and Better Serve Customers

Terumo, SURU, Weigao, AdvaCare, Fresenius, Grifols, Nanjing Cell-Gene Biomedical, Haemonetics, Suzhou Laishi Transfusion Equipment, Macopharma, Sichuan Nigale Biomedical, and JMS are among popular manufacturers operating in the global disposable plastic blood bag market. Market competition is expected to remain intense during the forecast period. Players could open new facilities to expand their presence in the global disposable plastic blood bag market. Early in 2019, Terumo Medical Canada, a subsidiary of Japanese medical devices manufacturer Terumo, opened a new 58,000 square foot office, distribution, and warehouse facility in Vaughan, Ontario.

By Product Type

● Quadruple Blood Bags

●  Triple Blood Bags

●  Double Blood Bags

●  Single Blood Bags

●  Others

By End User

●  Blood Banks

●  Hospitals

●  Others

Market analysts predict single blood bags to account for an impressive share of the global disposable plastic blood bag market. Single blood bags are available in different sizes, viz. 500 ml, 450 ml, 350 ml, and 250 ml. They are used to collect, preserve, and transfuse whole blood. CPAD-1 is the most common anticoagulant solution present in the primary bag of single blood bags. Among end users, blood banks are forecast to secure a commanding share of the global disposable plastic blood bag market in the coming years. Demand for disposable plastic blood bag is usually high in blood banks around the world.

By Region

     Followed by North America, Europe is anticipated to collect a healthy share of the global disposable plastic blood bag market in terms of consumption. This could be due to high requirement for blood and blood components in the region. North America is expected to show growth in the global disposable plastic blood bag market on the back of increased research and development investments and high incidence of blood disorders. Asia Pacific could also create rewarding opportunities for disposable plastic blood bag manufacturers as its population growth keeps increasing.

Life sciences is a wide branch of study that is gradually becoming an integral industry to the global economics. QYR Consulting looks at the steady transformation of the life sciences industry and its impact on the subindustries such as medical care, pharmaceutical, and medical devices. Our team of esteemed analysts have put together reports to analyze the monumental changes life sciences is expected to bring in the overall healthcare industry. These reports identify the exact turning points for the industry and open up a platform for discussing its growth.

QYR Consulting brings to you a structured analysis of the technological advancements so far, vision of the players in the industry, and the strategies they are likely to use to make their mark. The reports dissect various components of the life sciences industry to scrutinize the influential factors. To help the readers make profitable business decisions, analysts have highlighted the lucrative investment areas and upcoming business opportunities.